Literature DB >> 23593935

Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro.

Patricia Garcia1, Pamela Leal, Carmen Ili, Priscilla Brebi, Hector Alvarez, Juan C Roa.   

Abstract

Gallbladder cancer (GBC) is an aggressive neoplasm associated with late diagnosis, unsatisfactory treatment and poor prognosis. Previous work showed that connective tissue growth factor (CTGF) expression is increased in this malignancy. This matricellular protein plays an important role in various cellular processes and its involvement in the tumorigenesis of several human cancers has been demonstrated. However, the precise function of CTGF expression in cancer cells is yet to be determined. The aim of this study was to evaluate the CTGF expression in gallbladder cancer cell lines, and its effect on cell viability, colony formation and in vitro cell migration. CTGF expression was evaluated in seven GBC cell lines by Western blot assay. Endogenous CTGF expression was downregulated by lentiviral shRNA directed against CTGF mRNA in G-415 cells, and the effects on cell viability, anchorage-independent growth and migration was assessed by comparing them to scrambled vector-transfected cells. Knockdown of CTGF resulted in significant reduction in cell viability, colony formation and anchorage-independent growth (P < 0.05). An increased p27 expression was observed in G-415 cells with loss of CTGF function. Our results suggest that high expression of this protein in gallbladder cancer may confer a growth advantage for neoplastic cells.
© 2013 The Authors. International Journal of Experimental Pathology © 2013 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23593935      PMCID: PMC3664964          DOI: 10.1111/iep.12023

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  39 in total

1.  Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma.

Authors:  Martin Filipits; Harald Puhalla; Friedrich Wrba
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

2.  Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.

Authors:  Xiao-Qin Jia; Hai-Qing Cheng; Hong Li; Yan Zhu; Yu-Hua Li; Zhen-Qing Feng; Jian-Ping Zhang
Journal:  Chin Med J (Engl)       Date:  2011-11       Impact factor: 2.628

3.  CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts.

Authors:  D Kothapalli; G R Grotendorst
Journal:  J Cell Physiol       Date:  2000-01       Impact factor: 6.384

Review 4.  Present status of the diagnosis and treatment of gallbladder carcinoma.

Authors:  J H Donohue
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

5.  Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

Authors:  Naoya Fujita; Saori Sato; Kazuhiro Katayama; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

6.  Connective tissue growth factor is directly related to liver fibrosis.

Authors:  N Hayashi; T Kakimuma; Y Soma; G R Grotendorst; K Tamaki; M Harada; A Igarashi
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

7.  Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.

Authors:  Imtiaz A Malik; Zeba Aziz; S H Manzoor Zaidi; Gopalan Sethuraman
Journal:  Am J Clin Oncol       Date:  2003-04       Impact factor: 2.339

8.  Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy.

Authors:  Nadia Abdel-Wahab; Benjamin S Weston; Terry Roberts; Roger M Mason
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

Review 9.  Role of MAP kinase in tumor progression and invasion.

Authors:  Kaladhar B Reddy; Sanaa M Nabha; Natasha Atanaskova
Journal:  Cancer Metastasis Rev       Date:  2003-12       Impact factor: 9.264

Review 10.  The protein kinase B/Akt signalling pathway in human malignancy.

Authors:  Karleen M Nicholson; Neil G Anderson
Journal:  Cell Signal       Date:  2002-05       Impact factor: 4.315

View more
  6 in total

1.  CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer.

Authors:  Hyungjoo Kim; Seogho Son; Yunhyo Ko; Incheol Shin
Journal:  Oncogene       Date:  2021-03-10       Impact factor: 9.867

2.  The regulation of connective tissue growth factor expression influences the viability of human trabecular meshwork cells.

Authors:  Sabrina Kuespert; Benjamin Junglas; Barbara M Braunger; Ernst R Tamm; Rudolf Fuchshofer
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

3.  Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.

Authors:  Hou-Shan Yao; Chang Sun; Xin-Xing Li; Yi Wang; Kai-Zhou Jin; Xiao-Ping Zhang; Zhi-Qian Hu
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

4.  Mesenchymal stem cell-derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells.

Authors:  Yu-Ling Wu; Hong-Yu Li; Xiao-Peng Zhao; Jiu-Yang Jiao; Dong-Xiao Tang; Ling-Jian Yan; Quan Wan; Chao-Bin Pan
Journal:  Cancer Sci       Date:  2017-04-26       Impact factor: 6.716

5.  Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.

Authors:  Qianze Dong; Lin Fu; Yue Zhao; Yaming Du; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Oncotarget       Date:  2017-04-25

6.  TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma.

Authors:  Qianze Dong; Lin Fu; Yue Zhao; Chengyao Xie; Qingchang Li; Enhua Wang
Journal:  Oncotarget       Date:  2017-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.